Financials MedPlus Health Services Limited

Equities

MEDPLUS

INE804L01022

Drug Retailers

Market Closed - NSE India S.E. 12:43:52 15/05/2024 BST 5-day change 1st Jan Change
704.4 INR +0.56% Intraday chart for MedPlus Health Services Limited +2.46% -6.18%

Valuation

Fiscal Period: March 2022 2023 2024 2025 2026
Capitalization 1 121,036 77,513 84,196 - -
Enterprise Value (EV) 1 122,118 74,675 82,183 82,728 83,324
P/E ratio 119 x 156 x 162 x 74 x 44.5 x
Yield - - - - -
Capitalization / Revenue 3.2 x 1.7 x 1.49 x 1.23 x 1.04 x
EV / Revenue 3.23 x 1.64 x 1.45 x 1.2 x 1.03 x
EV / EBITDA 44.8 x 28.1 x 23.4 x 17.4 x 13.7 x
EV / FCF 234 x -95 x 80.2 x 33.5 x 24.9 x
FCF Yield 0.43% -1.05% 1.25% 2.99% 4.02%
Price to Book 17.1 x 10.4 x 5.45 x 5.1 x 4.59 x
Nbr of stocks (in thousands) 119,306 119,306 119,537 - -
Reference price 2 1,014 649.7 704.4 704.4 704.4
Announcement Date 30/05/22 25/05/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Net sales 1 - 37,793 45,576 56,682 68,721 80,610
EBITDA 1 - 2,724 2,657 3,512 4,767 6,071
EBIT 1 - 1,530 841.1 1,280 2,267 3,313
Operating Margin - 4.05% 1.85% 2.26% 3.3% 4.11%
Earnings before Tax (EBT) 1 - 1,179 471.6 669.8 1,514 2,530
Net income 1 638.6 958 497.6 518.4 1,137 1,890
Net margin - 2.53% 1.09% 0.91% 1.66% 2.34%
EPS 2 29.38 8.520 4.170 4.354 9.524 15.83
Free Cash Flow 1 - 521.7 -786 1,024 2,472 3,348
FCF margin - 1.38% -1.72% 1.81% 3.6% 4.15%
FCF Conversion (EBITDA) - 19.15% - 29.17% 51.87% 55.15%
FCF Conversion (Net income) - 54.45% - 197.63% 217.38% 177.14%
Dividend per Share - - - - - -
Announcement Date 18/08/21 30/05/22 25/05/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 9,659 9,937 11,206 11,903 12,530 12,843 14,058 14,502 14,890
EBITDA 1 - 522.8 526.4 596.7 717.2 816.3 713.4 676.7 622 823.7
EBIT - - - - - - - - - -
Operating Margin - - - - - - - - - -
Earnings before Tax (EBT) - - - - 162.1 - - - - -
Net income 1 171.7 - 32 65.65 134.1 265.8 37.86 93.5 111 182.7
Net margin - - 0.32% 0.59% 1.13% 2.12% 0.29% 0.67% 0.77% 1.23%
EPS 1.520 - - - 1.120 - - - - -
Dividend per Share - - - - - - - - - -
Announcement Date 14/02/22 30/05/22 10/08/22 11/11/22 03/02/23 25/05/23 07/08/23 - - -
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Net Debt 1 - 1,083 - - - -
Net Cash position 1 - - 2,838 2,013 1,468 872
Leverage (Debt/EBITDA) - 0.3975 x - - - -
Free Cash Flow 1 - 522 -786 1,025 2,473 3,348
ROE (net income / shareholders' equity) - 8.92% 3.42% 3.28% 7.08% 10.7%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 - 59.40 62.50 129.0 138.0 154.0
Cash Flow per Share - - 7.580 - - -
Capex 1 - 1,142 1,690 811 791 875
Capex / Sales - 3.02% 3.71% 1.43% 1.15% 1.09%
Announcement Date 18/08/21 30/05/22 25/05/23 - - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
704.4 INR
Average target price
878.4 INR
Spread / Average Target
+24.71%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MEDPLUS Stock
  4. Financials MedPlus Health Services Limited